swisschem bpc 157 Peptide BPC-157 - Does It Work? Breaking Down the Evidence and the Hype BPC-157 (0.5mg/capsule), 60 Capsules -

While this warning is primarily based on rodent studies and has not been confirmed in humans, cagrilintide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)

Children presenting neurological signs or symptoms, those unable to take oral medication, individuals with known malabsorption syndromes, infants under 6 months old, and patients using medications that may interfere with vitamin B12 absorption are typically treated with a parenteral protocol (1)

10.1073/pnas.1811787115 27 CalzettaL.RitondoB

-20C, 1 month (sealed storage, away from moisture) Solvent & Solubility In Vitro : H 2 O : 100 mg/mL ( 70.45 mM ) DMSO : 50 mg/mL ( 35.22 mM